Figure 2.
Overall survival regarding pathological complete response for Luminal A (A), Luminal B (B), HER2-enriched (C) and triple negative group (D).
Overall survival regarding pathological complete response for Luminal A (A), Luminal B (B), HER2-enriched (C) and triple negative group (D).